Drug recall
Apheresis Platelets, Platelet Additive Solution Added, Leukocytes Reduced
FDA recall event 84416 · Class III · LifeShare Blood Centers
Key facts
| Event ID | 84416 |
|---|---|
| Recall numbers | B-0169-2020 |
| Recalling firm | LifeShare Blood Centers |
| Product type | Biologics |
| Products | Apheresis Platelets, Platelet Additive Solution Added, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Plateletpheresis products, not meeting product specifications, were distributed. |
| Initiation date | Nov 5, 2019 |
| Report date | Dec 25, 2019 |
| Termination date | Dec 17, 2019 |
| City | Shreveport |
| State | LA |
| Country | United States |
| FEI number | 2370879 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: